Regeneron CEO talks drug pricing and tax reform

5:47 PM ET Tue, 9 Jan 2018

CNBC's Meg Tirrell speaks with Leonard Schleifer, Regeneron CEO, about how the company will benefit from tax cuts, as well as pricing competition among drug companies.